QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial 期刊论文 EUROPEAN JOURNAL OF CANCER, 2019, 卷号: 112 作者:  Zhang, Qingyuan;  Xu, Binghe;  Funasaka, Setsuo;  Saito, Kenichi;  Hiraiwa, Masahide 收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05 Progression-free survival  Tolerability  Locally recurrent or metastatic breast cancer  Eribulin   Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial 期刊论文 EUROPEAN JOURNAL OF CANCER, 2019, 卷号: 112 作者:  Yuan, Peng;  Hu, Xichun;  Sun, Tao;  Li, Wei;  Zhang, Qingyuan 收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05 Progression-free survival  Tolerability  Locally recurrent or metastatic breast cancer  Eribulin   Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial 期刊论文 LANCET ONCOLOGY, 2019, 卷号: 20, 期号: 6 作者:  Jiang, Zefei;  Li, Wei;  Hu, Xichun;  Zhang, Qingyuan;  Sun, Tao 收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05 Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文 2019, 卷号: 37, 期号: 29, 页码: 2610-2619 作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng 收藏  |  浏览/下载：32/0  |  提交时间：2020/01/03 Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial 期刊论文 2019, 卷号: 112, 页码: 57-65 作者:  Yuan, Peng;  Hu, Xichun;  Sun, Tao;  Li, Wei;  Zhang, Qingyuan 收藏  |  浏览/下载：20/0  |  提交时间：2020/01/03 Progression-free survival  Tolerability  Locally recurrent or metastatic breast cancer  Eribulin